Jorge Camarero

Jorge has more than 17 years of experience in the European Union’s regulatory system, primarily in oncology and rare diseases and in evaluating advanced therapies, small molecules, monoclonal antibodies, biosimilars, and other protein products. He served at the European Medicines Agency (EMA) in the Netherlands as a member of the Oncology Working Party and an alternate member of the Committee for Medicinal Products for Human Use. Before his tenure at the EMA, he was head of the oncology area for the Spanish Agency of Medicines and Medical Devices (AEMPS), a pharmaceutical inspector for the Spanish Government’s health department; and a regulatory clinical assessor in Oncology for the AEMPS. He provides strategic, regulatory, and technical advice to Parexel clients on clinical-development strategy, applications for scientific advice and accelerated pathways, and marketing authorization submissions.